Skip to main content

Table 3 Summary of tumor regression after IGF-IR downreguation (% reduction in volume)

From: ErbB2 enhances mammary tumorigenesis, oncogene-independent recurrence and metastasis in a model of IGF-IR-mediated mammary tumorigenesis

 

Number of tumors with full regression (100%)

Number of tumors with partial regression (10-99.9%)

Number of tumors with no/minimal regression (0-10%)

RM11A+Dox

3/11 (27.2%)

7/11 (63.6%)

1/11 (9.1%)

RM11A+Dox/ErbB2

0/14 (0.0%)

7/14 (50.0%)

7/14 (50.0%)

  1. Significantly different between the two conditions tested (p < 0.05)